Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...
HeartBeam has received FDA clearance for its synthesized 12-lead ECG software, making it the first cable-free device of its kind for at-home arrhythmia assessment. The clearance followed a successful ...
(RTTNews) - HeartBeam, Inc. (BEAT), a medical technology company, announced Wednesday that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the Company's groundbreaking ...
Under the agreement, MyoVista Insights and the MyoVista wavECG device will be used exclusively across UWE’s cardiac and physiological science teaching programs to train the next generation of cardiac ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results